期刊文献+

抵抗素对人子宫内膜癌细胞增殖、黏附及侵袭的影响 被引量:3

Effects of resistin on proliferation,adhesion and invasion of endometrial carcinoma cells
下载PDF
导出
摘要 目的研究抵抗素对人子宫内膜癌细胞系Ishikawa增殖、黏附及侵袭的影响。方法采用MTT法检测细胞的增殖活性及细胞黏附能力,实时定量PCR方法检测MMP-2、MMP-9及TIMP-1、TIMP-2的表达。结果10、50、100和150 ng/ml的抵抗素均能促进Ishikawa细胞的生长,并有时间和剂量依赖性,以100 ng/ml作用48 h的增殖作用最为明显,与对照组相比差异均有统计学意义(P<0.01);能增强细胞黏附能力,4个浓度的细胞黏附率分别为67%、69%、75%和98%,与对照组0%的黏附率比较差异有统计学意义(P<0.01);能促进MMP-2、MMP-9的表达,使MMPs/TIMPs的表达失衡,增强细胞侵袭能力。结论抵抗素可以促进子宫内膜癌细胞系Ishikawa的增殖,增强细胞的黏附及侵袭能力。 Objective To investigate the effect s of resistin on cell growth,adhesion and invasion of human endometrial carcinoma Ishikawa cells.Methods MTT assay was used to assess the proliferation and adhesion effects of resistin;and Real-Time PCR was adopted to detect the expressions of MMP-2,MMP-9,TIMP-1 and TIMP-2.Results Resistin at concentrations of 10,50,100 and 150 ng/ml promoted the proliferation of endometrial carcinoma cells in a time and dose-dependent manner(P0.01);the effect of resistin at 100 ng/ml for 48 h was most prominent.Resistin at a range of 10-150ng/ml enhanced the adhesive ability of Ishkawa cells,with the adherence rates of 67%,69%,75%and 98%,respectively(P0.01).Resistin enhanced the expressions of MMP-2, MMP-9,and induced the unbalance of MMPs/TIMPs ratio.Conclusion Resistin can promote the proliferation of endometrial carcinoma Ishikawa cells,and enhance its adhesive and invasive ability.
出处 《同济大学学报(医学版)》 CAS 2011年第5期46-51,共6页 Journal of Tongji University(Medical Science)
关键词 抵抗素 子宫内膜肿瘤 增殖 黏附 侵袭 resistin endometrial carcinoma proliferation adhesion invasion
  • 相关文献

参考文献16

  • 1Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2010[J]. CA Caner J Clin, 2010,57:43 -66.
  • 2杨丹,韩立敏.1969-2003年子宫内膜癌发病率及发病因素分析[J].复旦学报(医学版),2005,32(4):479-480. 被引量:33
  • 3Soliman PT, Oh JC, Schmeler KM, et al. Risk factors for young premenopausal women with endomeWial cancer [J]. Obstet Gynecol, 2005,105(3) : 575 -580.
  • 4Richardson LC, Thomas C, Browman BA. Obesity and endometrial cancer: challenges for public health action [J]. Women's Health, 2009,5(6) : 595 -597.
  • 5Di Simone N, Di Nicuolo F, Sanguinetti M, et al. Resistin regulates human choriocareinoma cell invasive behaviour and endothelial cell angiogenic processes[ J ]. J Endocrinol, 2006,189 (3) : 6912699.
  • 6Kang JH, Yu BY, Youn DS. Relationship of serum adiponectin and resistin levels with breast cancer risk [J]. J Korean Med Sci, 2007,22(1) : 117 -121.
  • 7Dimitrios P, Georgios K, Anargyros K, et al. Serum resistin levels in women with polycystie ovary syndrome [ J]. Fertil Steril, 2006,81(2) : 361 -366.
  • 8傅芝丽.抵抗素水平对子宫肌瘤发病和生长的影响[J].中国全科医学,2010,13(9):1012-1013. 被引量:3
  • 9Kapoor S. Matrix metalloproteinase-2(MMP-2): a major player in the progression of systemic malignancies besides endometrial serous carcinomas [ J ]. Acta Obstet Gynecol Scand, 2008,87(8) : 868 -874.
  • 10Mu H, Ohashi R, Yan S, et al. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells[J]. Cardiovase Res, 2006,70(1) : 146 - 157.

二级参考文献26

共引文献35

同被引文献44

  • 1Hong-qi FAN,Nan GU,Feng LIU,Li FEI,Xiao-qin PAN,Mei GUO,Rong-hua CHEN,Xi-rong GUO.Prolonged exposure to resistin inhibits glucose uptake in rat skeletal muscles[J].Acta Pharmacologica Sinica,2007,28(3):410-416. 被引量:16
  • 2HOU Wei-kai,XU Yu-xin,YU Ting,ZHANG Li,ZHANG Wen-wen,FU Chun-li,SUN Yu,WU Qing,CHEN Li.Adipocytokines and breast cancer risk[J].Chinese Medical Journal,2007(18):1592-1596. 被引量:11
  • 3Petridou I, Belechri M, Dessypris N, et al. Lep and BMI in relation to endometrial cancer risk[J]. Ann Nutr Metab, 2002, 46(2) :147-151.
  • 4Luhn P, Dallal C M, Weiss J M, et al. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial [J]. Cancer Epidemiol Biomarkers Prey,2013,22(7) : 1304- 1312.
  • 5Ashizawa N, Yahata T, Quan J, etal. Serum leptin adiponectin ratio and endometrial cancer risk in postmenopausai female subjects[J]. Gynecol Oncol,2010,119(1) :65-69.
  • 6Cust A E, Kaaks R, Friedenreieh C, et al. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women[J]. J Clin Endocrinol Mctab,2007,92(1):255-263.
  • 7Hlavana M, Kohut L, Lipkova J, et al. Relationship of resistin levels with endometrial cancer risk[J]. Neoplasma, 2011,58(2) :124-128.
  • 8Catalano S, Marsico S, Giordano C, et al. Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line[J]. J Biol Chem, 2003,278(31 ) : 28668-28676.
  • 9Gao J, Tian J, Lv Y, et al. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERP, and PI3K/AKT pathways in human endometrial cancer cells[J]. Cancer Sci,2009,100(3) :389-395.
  • 10Fogarty S, Hardie D G. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer [J]. Buicghim Biophys Acta,2010,1804(3) :581-591.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部